Ceritinib
-
Ceritinib
structure -
-
CAS No:
1032900-25-6
-
Formula:
C28H36ClN5O3S
-
Chemical Name:
Ceritinib
-
Synonyms:
2,4-Pyrimidinediamine,5-chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-;5-Chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine;LDK 378;Ceritinib;Zykadia;1431456-10-8
- Categories:
-
CAS No:
Description
ChEBI: A member of the class of aminopyrimidines that is 2,6-diamino-5-chloropyrimidine in which the amino groups at positions 2 and 6 are respectively carrying 2-methoxy-4-(piperidin-4-yl)-5-methylphenyl and 2-(isopropylsulfonyl)phenyl substituents. Used for the treatment of ALK-positive metastatic non-small cell lung cancer.
Ceritinib Use and Manufacturing
The intermediate P4 was dissolved in anhydrous DCM, EDCI and Hobt were added, and finally LDK378 was added, and the reaction was carried out at room temperature for 12 h.After the reaction was completed, water was added, extracted with EA three times, the organic layer was washed twice with saturated brine, dried over anhydrous sodium sulfate, concentrated, and the target product was separated by column chromatography with a yield of about 65%.Sebacic acid was used as a raw material (202 mg, 1 mmol), dissolved in 20 mL of DMF, and HATU (1140 mg, 3 mmol), DIPEA (774 mg, 6 mmol), LDK378 (279 mg, 0.5 mmol) were stirred at room temperature for 10 h.The reaction progress was monitored by TLC. After the reaction was completed, the reaction was quenched with 30 mL of water. After the aqueous layer was extracted with EA, the organic layers were combined, backwashed with saturated brine, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and then DCM / MeOH. Column chromatography was performed as the mobile phase. A white solid was obtained with a yield of about 53%.LDK378 was used as a raw material (330 mg, 0.6 mmol), dissolved in 50 mL of methanol, methyl acrylate (78 mg, 0.9 mmol) and triethylamine (240 mg, 2.4 mmol) were added, and the mixture was stirred at room temperature for 8 h.TLC measures the progress of the reaction.Treatment method: first remove the methanol by distillation under reduced pressure, add 150 mL of ethyl acetate, backwash the organic solution three times with water, remove the water with anhydrous sodium sulfate and concentrate under reduced pressure, and perform column chromatography with a PE / EA separation system to obtain a white solid.The yield is about 90%.Using LDK378 as a raw material (330mg, 0.6mmol), dissolved in 50mL methanol, Methyl acrylate (78 mg, 0.9 mmol) and triethylamine (240 mg, 2.4 mmol) were added, and the mixture was stirred at room temperature for 8 h. The progress of the reaction was monitored by TLC. Treatment method: first remove the methanol by distillation under reduced pressure, add 150 mL of ethyl acetate, backwash the organic solution three times with water, remove the water with anhydrous sodium sulfate and concentrate under reduced pressure, and perform column chromatography with a PE / EA separation system to obtain a white solid. The yield is about 90%.LDK378 was used as a raw material (330 mg, 0.6 mmol), dissolved in 50 mL of methanol, methyl acrylate (78 mg, 0.9 mmol), triethylamine (240 mg, 2.4 mmol) were added, and the mixture was stirred at room temperature for 8 h. The reaction progress was detected by TLC. Treatment method: first remove the methanol by distillation under reduced pressure, add 150 mL of ethyl acetate, backwash the organic solution three times with water, remove the water with anhydrous sodium sulfate, and concentrate under reduced pressure. Column chromatography using a PE / EA separation system to obtain a white solid. The yield is about 90%.
Recommended Suppliers of Ceritinib
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Custom Synthetic Chemicals,Biological Stains,Pharmaceutical Intermediates,Cosmetic Grade Chemicals,Enzyme,Nucleosides,Indicators,Speciality Chemicals,Biological Chemicals,Enzyme SubstratesInquiryUnit Price: $80-85 /KG FOBCAS No.: 1032900-25-6Grade: Reagent GradeContent: 99% -
CN
4 YRS
Business licensedTrader Supplier of additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst,API -
CN
6 YRS
Business licensed Certified factoryManufactory Supplier of Chloranil,Ascomycin,Gemcitabine,Levamlodipine,Isoflurane,1-(4-Pyridyl)acetone,Peramivir,SiO2,Aluminum oxide,Posaconazole Main Ring,Rapamycin,Clemastine fumarate,Tacrolimus,SiO,Milrinone,Benzyl alcohol,Isavuconazole intermediate,Clofarabine,Prasugrel,Daptomycin,hydroxyapatite,1,Atracurium oxalate,Atazanavir sulfate,Decitabine,Zirconium dioxide,5-Pentanediol diacrylate,Darunavir,Vorapaxar intermediate,Meloxicam,Carfilzomib,Miglitol,Isavuconazole -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 1032900-25-6Grade: Industrial GradeContent: 99%
Latest News on Ceritinib
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4